- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gout Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gout Therapeuticsmarket, defines the market attractiveness level of Gout Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gout Therapeutics industry, describes the types of Gout Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gout Therapeutics market and the development prospects and opportunities of Gout Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gout Therapeutics market in Chapter 13.
By Player:
Takeda Pharmaceutical Company
Novartis
Teijin Pharma
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals
By Type:
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents
By End-User:
Acute Gout
Chronic Gout
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gout Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gout Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gout Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gout Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gout Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Gout Therapeutics Consumption (2017-2022)
-
7.2 United States Gout Therapeutics Consumption (2017-2022)
-
7.3 Europe Gout Therapeutics Consumption (2017-2022)
-
7.4 China Gout Therapeutics Consumption (2017-2022)
-
7.5 Japan Gout Therapeutics Consumption (2017-2022)
-
7.6 India Gout Therapeutics Consumption (2017-2022)
-
7.7 South Korea Gout Therapeutics Consumption (2017-2022)
8 Region and Country-wise Gout Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Gout Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Gout Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Gout Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Gout Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Gout Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Gout Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Gout Therapeutics Consumption Forecast (2022-2028)
9 Global Gout Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Gout Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global NSAIDs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Colchicine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Urate-Lowering Agents Consumption and Growth Rate (2017-2022)
-
9.2 Global Gout Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute Gout Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Chronic Gout Consumption and Growth Rate (2017-2022)
10 Global Gout Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Gout Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Colchicine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Urate-Lowering Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gout Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acute Gout Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Chronic Gout Consumption Forecast and Growth Rate (2022-2028)
11 Global Gout Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gout Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gout Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gout Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gout Therapeutics Market Competitive Analysis
-
14.1 Takeda Pharmaceutical Company
-
14.1.1 Takeda Pharmaceutical Company Company Details
-
14.1.2 Takeda Pharmaceutical Company Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceutical Company Gout Therapeutics Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Gout Therapeutics Product and Service
-
14.3 Teijin Pharma
-
14.3.1 Teijin Pharma Company Details
-
14.3.2 Teijin Pharma Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teijin Pharma Gout Therapeutics Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Gout Therapeutics Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Gout Therapeutics Product and Service
-
14.6 Regeneron Pharmaceuticals
-
14.6.1 Regeneron Pharmaceuticals Company Details
-
14.6.2 Regeneron Pharmaceuticals Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Regeneron Pharmaceuticals Gout Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gout Therapeutics
-
Figure Gout Therapeutics Picture
-
Table Global Gout Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gout Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gout Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gout Therapeutics Consumption by Country (2017-2022)
-
Figure United States Gout Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Gout Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Gout Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Gout Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Gout Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gout Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Gout Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Gout Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gout Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gout Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gout Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gout Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gout Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NSAIDs Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Colchicine Consumption and Growth Rate (2017-2022)
-
Figure Global Urate-Lowering Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Gout Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Gout Consumption and Growth Rate (2017-2022)
-
Figure Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colchicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urate-Lowering Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Gout Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Gout Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gout Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gout Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Gout Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Gout Therapeutics Product and Service
-
Table Teijin Pharma (Foundation Year, Company Profile and etc.)
-
Table Teijin Pharma Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teijin Pharma Gout Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Gout Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Gout Therapeutics Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Gout Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Gout Therapeutics Product and Service
-